Infants exposed in the womb to Depakote, a drug commonly prescribed for seizures, migraines and depression, have consistently lower IQ's and higher levels of mental retardation than unexposed children ...

WASHINGTON (AP) -- Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food ...

Abbott Laboratories has been hit with the second largest healthcare fraud penalty in the USA after reaching a settlement concerning past sales and marketing practices relating to its seizure drug ...

Abbott Laboratories said Monday that it will pay $1.6 billion to settle federal and state claims that it illegally marketed the anti-seizure medication Depakote for uses not approved by the Food and ...

A new study published in Science Translational Medicine could introduce a profitable opportunity for makers of seizure drug medications. The discovery has immense medical implications, of course, but ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. (Crain's) — Illinois will get $20 million from settlements ...

The Food and Drug Administration is warning physicians that women who suffer migraine headaches and are pregnant or may become pregnant should not use the drugs valproate or valproic acid to prevent ...

Although Depakote was only approved for treating epileptic seizures, bipolar mania and migraines, the company admitted to maintaining a specialized sales force that promoted the drug for helping to ...

WASHINGTON – Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug ...